Journal
JOURNAL OF THROMBOSIS AND THROMBOLYSIS
Volume 41, Issue 1, Pages 187-205Publisher
SPRINGER
DOI: 10.1007/s11239-015-1319-y
Keywords
Anticoagulation; Warfarin; Coumadin; Venous thromboembolism; Anticoagulation clinics; Anticoagulation-related bleeding; Drug interactions; INR; Risk factors; Direct oral anticoagulants (DOAC)
Funding
- Boehringer Ingelheim
- Daiichi Sankyo
- Janssen Pharmaceuticals
Ask authors/readers for more resources
Venous thromboembolism (VTE) is a serious and often fatal medical condition with an increasing incidence. The treatment of VTE is undergoing tremendous changes with the introduction of the new direct oral anticoagulants and clinicians need to understand new treatment paradigms. This article, initiated by the Anticoagulation Forum, provides clinical guidance based on existing guidelines and consensus expert opinion where guidelines are lacking. Well-managed warfarin therapy remains an important anticoagulant option and it is hoped that anticoagulation providers will find the guidance contained in this article increases their ability to achieve optimal outcomes for their patients with VTE Pivotal practical questions pertaining to this topic were developed by consensus of the authors and were derived from evidence-based consensus statements whenever possible. The medical literature was reviewed and summarized using guidance statements that reflect the consensus opinion(s) of all authors and the endorsement of the Anticoagulation Forum's Board of Directors. In an effort to provide practical and implementable information about VTE and its treatment, guidance statements pertaining to choosing good candidates for warfarin therapy, warfarin initiation, optimizing warfarin control, invasive procedure management, excessive anticoagulation, subtherapeutic anticoagulation, drug interactions, switching between anticoagulants, and care transitions are provided.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available